This week, Congressman Bob Latta (R-OH5) led a bipartisan letter to the Department of Health and Human Services to request that the increased funding for the Public Health and Social Services Emergency Fund through the CARES Act is equitably distributed to small rural hospitals, critical access hospitals and other rural providers who are in grave need of help as they combat the coronavirus pandemi... Read more »
Today, Congressman Bob Latta (R-OH5) provided the following statement after voting in support of funding to respond to the coronavirus: “Ensuring the American people are safe is the most important job of government. I am relieved House Democrats agreed to put politics aside in order to join House Republicans in providing the Centers for Disease Control and Prevention, the Food and Drug Administrat... Read more »
This month, Congressman Bob Latta (R-OH5) introduced H.R. 5833, legislation working to increase accessibility to non-opioid treatment for those suffering from chronic pain. People who are suffering from chronic pain often turn to opioids to alleviate their discomfort, which in some cases, has led to a rise of misuse and abuse. Opioid alternatives, including certain medical devices and procedures, ... Read more »
Today, U.S. Representatives Bob Latta (R-OH5) and Steve Chabot (R-OH1) introduced legislation to provide the U.S. Drug Enforcement Administration (DEA) the ability to criminalize the manufacturing, distribution or possession of fentanyl-like drugs. Specifically, H.R. 5771, the Federal Initiative to Guarantee Health by Targeting (FIGHT) Fentanyl Act, will permanently list all fentanyl analog drugs ... Read more »
Today, Congressman Bob Latta (R-OH5) joined the Energy and Commerce Subcommittee on Oversight and Investigations to further examine the state efforts underway to curb the opioid crisis and to shine a spotlight on the importance of legislation Latta authored, the Indexing Narcotics, Fentanyl and Opioids (INFO) Act. The INFO Act was a core part of H.R.6, the SUPPORT Act, that was signed into law in ... Read more »
Click HERE to watch Congressman Latta speak on the House floor in support of the bipartisan Lower Costs, More Cures Act. Today, Congressman Bob Latta (R-OH5) voted against H.R.3, a partisan bill that would result in fewer cures, would harm innovation, and will never become law. Instead, Congressman Latta voted in support of H.R. 19, the Lower Costs, More Cures Act, a bipartisan plan that would low... Read more »
Congressman Bob Latta (R-OH5) penned an op-ed in the Lima News shining a spotlight on the Lower Costs, More Cures Act, a bipartisan plan for lowering the costs of prescription medications for people across the country. Bipartisan plan better for people needing medicine By: Congressman Bob Latta (R-OH5) December 11, 2019 As the cost of prescription drugs continues to skyrocket from sea to shining ... Read more »
Today, the Energy and Commerce Committee concluded a two-day markup where members voted to pass a number of bipartisan bills working to improve health care access for new and expecting mothers, increase rural broadband capabilities, boost our economy, and more. Congressman Latta released the following statement at the conclusion of today’s markup: “The bipartisan bills the Committee passed work to... Read more »
On the one year anniversary of President Trump signing H.R. 6, the SUPPORT Act, into law, Congressman Bob Latta (R-Bowling Green) has introduced two new pieces of legislation to address the opioid crisis. Legislation that Latta had previously authored, the Indexing Narcotics, Fentanyl, and Opioids (INFO) Act, was included in H.R. 6. The Department of Health and Human Services is currently implemen... Read more »
Congressman Bob Latta (R-Bowling Green) authored a column in today’s Findlay Courier that reflects on the progress made to curb the opioid epidemic in the last year. On October 24, 2018, President Trump signed H.R. 6, the SUPPORT Act into law. That legislation was the most comprehensive effort to combat a drug crisis in U.S. history. The article can be seen in the Ecourier edition available here. ... Read more »
